Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome

BACKGROUND: Ischemia-modified albumin (IMA) has been suggested as a marker of cardiac ischemia. Little, however, is known about its capacity to predict short-term serious cardiac outcomes (death, myocardial infarction, congestive heart failure, serious arrhythmia, or refractory ischemic cardiac pain...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Worster, Andrew, Devereaux, P.J., Heels-Ansdell, Diane, Guyatt, Gordon H., Opie, John, Mookadam, Farouk, Hill, Stephen A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Canadian Medical Association 2005
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1150260/
https://ncbi.nlm.nih.gov/pubmed/15967971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.045194
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi